Qsam Biosciences Inc

General ticker "QSAM" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $17.8M

Qsam Biosciences Inc follows the US Stock Market performance with the rate: 42.7%.

Estimated limits based on current volatility of 3.4%: low 7.63$, high 8.17$

Factors to consider:

  • Earnings expected soon, date: 2024-05-13

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 predicted range: [2.81$, 7.51$]
  • 2024-12-30 to 2025-12-30 predicted range: [1.46$, 4.64$]

Financial Metrics affecting the QSAM estimates:

  • Negative: Non-GAAP EPS of -1.79 <= 0.09
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: Operating Cash Flow per share of -0.94 <= 0.22
  • Negative: negative Net Income
  • Positive: Interest Expense per share of 0.02 <= 0.20
  • Negative: Industry Operating Cash Flow per share (median) of -1.49 <= 0.29

Similar symbols

Short-term QSAM quotes

Long-term QSAM plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $11.04MM $5.46MM $3.94MM
Operating Income $-11.04MM $-5.46MM $-3.94MM
Non-Operating Income $-0.94MM $-0.02MM $-0.45MM
Interest Expense $0.79MM $0.07MM $0.05MM
R&D Expense $0.65MM $1.02MM $1.16MM
Income(Loss) $-11.98MM $-5.48MM $-4.39MM
Taxes $0.79MM $0.59MM $0.00MM
Profit(Loss) $-12.77MM $-6.07MM $-4.39MM
Stockholders Equity $0.28MM $-1.22MM $0.67MM
Assets $1.67MM $0.36MM $1.71MM
Operating Cash Flow $-1.73MM $-2.71MM $-2.85MM
Financing Cash Flow $3.23MM $1.44MM $4.01MM
Earnings Per Share* $-16.13 $-3.45 $-1.44

* EPS are Split Adjusted, recent splits may be reflected with a delay.